Novel vitamin D hydroxyderivatives inhibit melanoma growth and show differential effects on normal melanocytes.

Abstract

Novel secosteroids show potent anti-melanoma activity in vitro with 20(OH)D(3) and 20,23(OH)(2)D(3) being excellent candidates for pre-clinical testing.